Stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Pilar SamperC Vallejo OcañaM Martin MartinF J Celada ÁlvarezD Farga AlbiolP Almendros BlancoA Hernandez MachancosesM Rico OsesS Flamarique AnduezaF Romero RupertoC Maria BuenoE Amaya EscobarL L Guerrero GómezF CouñagoMª Del Pino AlcántaraMª J Ruiz VillarJ L Monroy AntónP Saez BuenoJ Luna TiradoMª Del Mar PuertasA BoboI Diaz de Cerio MartínezN Gascon CostosoC Ferrer AlbiachPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)
SBRT is an effective and well-tolerated treatment option for patients with early-stage lung cancer who are not suitable for surgery. The most important prognostic factor for local and distant recurrence was complete response, which in our sample depended on the type of CT planning and the IGRT technique.
Keyphrases
- early stage
- prognostic factors
- sentinel lymph node
- radiation therapy
- minimally invasive
- computed tomography
- coronary artery bypass
- lymph node
- rectal cancer
- squamous cell carcinoma
- magnetic resonance imaging
- locally advanced
- dual energy
- magnetic resonance
- contrast enhanced
- free survival
- radiation induced
- replacement therapy
- smoking cessation